132 related articles for article (PubMed ID: 34282808)
1. Viral stimulation modulates endotype-related ACE2 expression in eosinophilic chronic rhinosinusitis.
Hong SN; Kim JK; Kim JA; Cha H; Kim JY; Lim HS; Eun KM; Kim DW
Rhinology; 2021 Oct; 59(5):460-469. PubMed ID: 34282808
[TBL] [Abstract][Full Text] [Related]
2. Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps.
Wang M; Bu X; Fang G; Luan G; Huang Y; Akdis CA; Wang C; Zhang L
Allergy; 2021 Mar; 76(3):789-803. PubMed ID: 33210729
[TBL] [Abstract][Full Text] [Related]
3. Co-Expression and Localization of Angiotensin-Converting Enzyme-2 (ACE2) and the Transmembrane Serine Protease 2 (TMPRSS2) in Paranasal Ciliated Epithelium of Patients with Chronic Rhinosinusitis.
Kawasumi T; Takeno S; Ishino T; Ueda T; Hamamoto T; Takemoto K; Horibe Y; Takashi O
Am J Rhinol Allergy; 2022 May; 36(3):313-322. PubMed ID: 34989246
[TBL] [Abstract][Full Text] [Related]
4. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.
Kimura H; Francisco D; Conway M; Martinez FD; Vercelli D; Polverino F; Billheimer D; Kraft M
J Allergy Clin Immunol; 2020 Jul; 146(1):80-88.e8. PubMed ID: 32422146
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.
Takabayashi T; Yoshida K; Imoto Y; Schleimer RP; Fujieda S
Am J Rhinol Allergy; 2022 Jan; 36(1):115-122. PubMed ID: 34232770
[TBL] [Abstract][Full Text] [Related]
6. Fluticasone Propionate Suppresses Poly(I:C)-Induced ACE2 in Primary Human Nasal Epithelial Cells.
Nakazono A; Nakamaru Y; Ramezanpour M; Kondo T; Watanabe M; Hatakeyama S; Kimura S; Honma A; Wormald PJ; Vreugde S; Suzuki M; Homma A
Front Cell Infect Microbiol; 2021; 11():655666. PubMed ID: 33981629
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
9. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells.
Peng J; Sun J; Zhao J; Deng X; Guo F; Chen L
J Transl Med; 2021 Aug; 19(1):358. PubMed ID: 34412632
[TBL] [Abstract][Full Text] [Related]
10. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
11. Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD.
Burgueño JF; Reich A; Hazime H; Quintero MA; Fernandez I; Fritsch J; Santander AM; Brito N; Damas OM; Deshpande A; Kerman DH; Zhang L; Gao Z; Ban Y; Wang L; Pignac-Kobinger J; Abreu MT
Inflamm Bowel Dis; 2020 May; 26(6):797-808. PubMed ID: 32333601
[TBL] [Abstract][Full Text] [Related]
12. Epipharyngeal Abrasive Therapy Down-regulates the Expression of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2.
Nishi K; Yoshimoto S; Nishi S; Tsunoda T; Ohno J; Yoshimura M; Hiromatsu K; Yamano T
In Vivo; 2022; 36(1):371-374. PubMed ID: 34972736
[TBL] [Abstract][Full Text] [Related]
13. Expression of ACE2, TMPRSS2, and SARS-CoV-2 nucleocapsid protein in gastrointestinal tissues from COVID-19 patients and association with gastrointestinal symptoms.
Lin L; Zeng F; Mai L; Gao M; Fang Z; Wu B; Huang S; Shi H; He J; Liu Y; Li X; Li Z; Han Y; Yan Z
Am J Med Sci; 2023 Dec; 366(6):430-437. PubMed ID: 37660993
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
Roehrich H; Yuan C; Hou JH
Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
[TBL] [Abstract][Full Text] [Related]
16. Targeting TMPRSS2 in SARS-CoV-2 Infection.
Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung.
Miura Y; Ohkubo H; Nakano A; Bourke JE; Kanazawa S
Front Immunol; 2022; 13():1028613. PubMed ID: 36405683
[TBL] [Abstract][Full Text] [Related]
18. Age-associated changes in chronic rhinosinusitis endotypes.
Ryu G; Dhong HJ; Park M; Hwang NY; Kim DK; Kim HY; Chung SK; Rhee CS; Cho SH; Hong SD; Kim DW
Clin Exp Allergy; 2020 May; 50(5):585-596. PubMed ID: 32053269
[TBL] [Abstract][Full Text] [Related]
19. Soluble ACE2 and TMPRSS2 Levels in the Serum of Asthmatic Patients.
Lee JH; Lee CE; Yoo Y; Shin E; An J; Park SY; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Korean Med Sci; 2022 Feb; 37(8):e65. PubMed ID: 35226423
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibitors on ACE1, ACE2, and TMPRSS2 expression and spheroid attachment on human endometrial Ishikawa cells.
Fernando SR; Chen X; Cheng KW; Wong BP; Qi S; Jiang L; Kodithuwakku SP; Ng EH; Yeung WS; Lee KF
Reprod Biol; 2022 Sep; 22(3):100666. PubMed ID: 35688117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
